What Happened?
Raleigh, NC-based 9-Meters Resigned Ed Sitar as Chief Financial Officer
About the Company
9 Meters Biopharma is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, GI conditions with unmet needs, and debilitating disorders in which the biology of the gut is a contributing factor. The Company is advancing vurolenatide, a proprietary Phase 2 long-acting GLP-1 agonist, for short bowel syndrome (SBS), larazotide, a Phase 3 tight junction regulator in non-responsive celiac disease, and several near clinical-stage assets.
About the Person
Ed Sitar is Chief Financial Officer at 9 Meters. Previously, Ed held various senior HR leadership roles in the industry.
Info Source
News
Short Profile